ラクオリア創薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/10 | 1,108 | 1,119 | 1,100 | 1,118 | -4 | -0.4% | 89,900 |
| 2022/11/09 | 1,111 | 1,125 | 1,107 | 1,122 | +11 | +1% | 62,000 |
| 2022/11/08 | 1,114 | 1,129 | 1,110 | 1,111 | +4 | +0.4% | 70,900 |
| 2022/11/07 | 1,119 | 1,119 | 1,098 | 1,107 | -15 | -1.3% | 100,000 |
| 2022/11/04 | 1,122 | 1,137 | 1,120 | 1,122 | -16 | -1.4% | 91,300 |
| 2022/11/02 | 1,141 | 1,142 | 1,129 | 1,138 | -10 | -0.9% | 70,200 |
| 2022/11/01 | 1,157 | 1,182 | 1,140 | 1,148 | ±0 | ±0% | 114,800 |
| 2022/10/31 | 1,166 | 1,171 | 1,148 | 1,148 | -11 | -0.9% | 93,400 |
| 2022/10/28 | 1,140 | 1,168 | 1,140 | 1,159 | +4 | +0.3% | 89,300 |
| 2022/10/27 | 1,114 | 1,166 | 1,114 | 1,155 | +43 | +3.9% | 229,800 |
| 2022/10/26 | 1,116 | 1,135 | 1,106 | 1,112 | ±0 | ±0% | 123,600 |
| 2022/10/25 | 1,110 | 1,122 | 1,102 | 1,112 | +2 | +0.2% | 100,300 |
| 2022/10/24 | 1,122 | 1,128 | 1,091 | 1,110 | ±0 | ±0% | 160,800 |
| 2022/10/21 | 1,140 | 1,140 | 1,098 | 1,110 | -49 | -4.2% | 296,600 |
| 2022/10/20 | 1,085 | 1,245 | 1,070 | 1,159 | +61 | +5.6% | 1,851,700 |
| 2022/10/19 | 1,106 | 1,116 | 1,090 | 1,098 | -13 | -1.2% | 91,800 |
| 2022/10/18 | 1,076 | 1,115 | 1,076 | 1,111 | +29 | +2.7% | 173,800 |
| 2022/10/17 | 1,064 | 1,082 | 1,063 | 1,082 | +4 | +0.4% | 67,600 |
| 2022/10/14 | 1,066 | 1,094 | 1,060 | 1,078 | +22 | +2.1% | 133,200 |
| 2022/10/13 | 1,080 | 1,080 | 1,051 | 1,056 | -18 | -1.7% | 99,100 |
| 2022/10/12 | 1,071 | 1,080 | 1,066 | 1,074 | +3 | +0.3% | 92,500 |
| 2022/10/11 | 1,073 | 1,082 | 1,067 | 1,071 | -17 | -1.6% | 65,300 |
| 2022/10/07 | 1,070 | 1,098 | 1,065 | 1,088 | +10 | +0.9% | 72,400 |
| 2022/10/06 | 1,082 | 1,086 | 1,074 | 1,078 | +8 | +0.7% | 44,400 |
| 2022/10/05 | 1,069 | 1,081 | 1,063 | 1,070 | +9 | +0.8% | 61,100 |
| 2022/10/04 | 1,062 | 1,068 | 1,054 | 1,061 | +17 | +1.6% | 78,000 |
| 2022/10/03 | 1,029 | 1,050 | 1,015 | 1,044 | ±0 | ±0% | 52,200 |
| 2022/09/30 | 1,034 | 1,054 | 1,030 | 1,044 | -2 | -0.2% | 73,300 |
| 2022/09/29 | 1,036 | 1,060 | 1,028 | 1,046 | +35 | +3.5% | 77,300 |
| 2022/09/28 | 1,029 | 1,048 | 1,007 | 1,011 | -19 | -1.8% | 102,000 |
| 2022/09/27 | 1,014 | 1,041 | 1,007 | 1,030 | +24 | +2.4% | 108,000 |
| 2022/09/26 | 1,009 | 1,033 | 1,005 | 1,006 | -28 | -2.7% | 118,700 |
| 2022/09/22 | 1,000 | 1,044 | 999 | 1,034 | +21 | +2.1% | 131,500 |
| 2022/09/21 | 1,030 | 1,035 | 1,002 | 1,013 | -33 | -3.2% | 170,100 |
| 2022/09/20 | 1,084 | 1,085 | 1,036 | 1,046 | -39 | -3.6% | 216,000 |
| 2022/09/16 | 1,095 | 1,099 | 1,076 | 1,085 | -26 | -2.3% | 172,600 |
| 2022/09/15 | 1,135 | 1,135 | 1,109 | 1,111 | -12 | -1.1% | 120,000 |
| 2022/09/14 | 1,120 | 1,153 | 1,119 | 1,123 | -32 | -2.8% | 237,500 |
| 2022/09/13 | 1,149 | 1,163 | 1,138 | 1,155 | +10 | +0.9% | 136,600 |
| 2022/09/12 | 1,149 | 1,153 | 1,131 | 1,145 | +1 | +0.1% | 159,300 |
| 2022/09/09 | 1,099 | 1,157 | 1,098 | 1,144 | +51 | +4.7% | 338,900 |
| 2022/09/08 | 1,114 | 1,114 | 1,081 | 1,093 | +8 | +0.7% | 132,600 |
| 2022/09/07 | 1,116 | 1,116 | 1,075 | 1,085 | -28 | -2.5% | 155,000 |
| 2022/09/06 | 1,078 | 1,131 | 1,073 | 1,113 | +39 | +3.6% | 224,900 |
| 2022/09/05 | 1,040 | 1,074 | 1,018 | 1,074 | +34 | +3.3% | 128,600 |
| 2022/09/02 | 1,052 | 1,057 | 1,010 | 1,040 | -6 | -0.6% | 132,500 |
| 2022/09/01 | 1,062 | 1,062 | 1,040 | 1,046 | -11 | -1% | 125,500 |
| 2022/08/31 | 1,067 | 1,075 | 1,050 | 1,057 | -11 | -1% | 112,400 |
| 2022/08/30 | 1,064 | 1,070 | 1,053 | 1,068 | +8 | +0.8% | 102,000 |
| 2022/08/29 | 1,065 | 1,076 | 1,052 | 1,060 | -30 | -2.8% | 148,300 |
501～
550
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
| ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
| 仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム
